| Patrick L Fabrizio, MD | |
|
100 Michigan St Ne, Grand Rapids, MI 49503-2560 | |
| (616) 391-1830 | |
| (616) 391-1286 |
| Full Name | Patrick L Fabrizio |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 29 Years |
| Location | 100 Michigan St Ne, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356350938 | NPI | - | NPPES |
| 920005690 | Other | MI | RAILROAD MEDICARE |
| 4236100 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0001X | Radiology - Radiation Oncology | 4301065539 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spectrum Health | Grand rapids, MI | Hospital |
| Spectrum Health Reed City Hospital | Reed city, MI | Hospital |
| Spectrum Health Big Rapids Hospital | Big rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Radiation Oncology Centers Pc | 2860437092 | 8 |
News Archive
A new paper published on the preprint server medRxiv in April 2020 suggests, based on mathematical models, that premature removal of lockdown restrictions in India could be highly counterproductive, enhancing the secondary spread of COVID-19, pushing up the number of fatalities and prolonging the course of the pandemic in India.
Uninterrupted treatment with dabigatran, a non-vitamin K antagonist oral anticoagulant (NOACs), before, during and after ablation to treat atrial fibrillation significantly reduced the incidence of major bleeding events compared with uninterrupted use of the more established anticoagulant warfarin, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
News reports of a teenager unable to free a toddler from a burning vehicle's child safety seat helped convince a Rome, Ga. dentist his idea of an alternative quick release mechanism for such seats was needed.
Senetek PLC today announced the closing of a Security Purchase Agreement, a Note and a Warrant Purchase Agreement DMRJ Group, LLC on March 4, 2010. DMRJ Group, LLC is a Delaware limited liability company affiliated with Platinum Partners Value Arbitrage Fund L.P., an accredited institutional investor with its investment manager headquartered in New York, New York.
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
› Verified 6 days ago
| Entity Name | Radiation Oncology Centers Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073610713 PECOS PAC ID: 2860437092 Enrollment ID: O20050628000225 |
News Archive
A new paper published on the preprint server medRxiv in April 2020 suggests, based on mathematical models, that premature removal of lockdown restrictions in India could be highly counterproductive, enhancing the secondary spread of COVID-19, pushing up the number of fatalities and prolonging the course of the pandemic in India.
Uninterrupted treatment with dabigatran, a non-vitamin K antagonist oral anticoagulant (NOACs), before, during and after ablation to treat atrial fibrillation significantly reduced the incidence of major bleeding events compared with uninterrupted use of the more established anticoagulant warfarin, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
News reports of a teenager unable to free a toddler from a burning vehicle's child safety seat helped convince a Rome, Ga. dentist his idea of an alternative quick release mechanism for such seats was needed.
Senetek PLC today announced the closing of a Security Purchase Agreement, a Note and a Warrant Purchase Agreement DMRJ Group, LLC on March 4, 2010. DMRJ Group, LLC is a Delaware limited liability company affiliated with Platinum Partners Value Arbitrage Fund L.P., an accredited institutional investor with its investment manager headquartered in New York, New York.
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
› Verified 6 days ago
| Entity Name | Compass Healthcare Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932533692 PECOS PAC ID: 6002045895 Enrollment ID: O20140127000294 |
News Archive
A new paper published on the preprint server medRxiv in April 2020 suggests, based on mathematical models, that premature removal of lockdown restrictions in India could be highly counterproductive, enhancing the secondary spread of COVID-19, pushing up the number of fatalities and prolonging the course of the pandemic in India.
Uninterrupted treatment with dabigatran, a non-vitamin K antagonist oral anticoagulant (NOACs), before, during and after ablation to treat atrial fibrillation significantly reduced the incidence of major bleeding events compared with uninterrupted use of the more established anticoagulant warfarin, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
News reports of a teenager unable to free a toddler from a burning vehicle's child safety seat helped convince a Rome, Ga. dentist his idea of an alternative quick release mechanism for such seats was needed.
Senetek PLC today announced the closing of a Security Purchase Agreement, a Note and a Warrant Purchase Agreement DMRJ Group, LLC on March 4, 2010. DMRJ Group, LLC is a Delaware limited liability company affiliated with Platinum Partners Value Arbitrage Fund L.P., an accredited institutional investor with its investment manager headquartered in New York, New York.
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Patrick L Fabrizio, MD Po Box 3525, Evansville, IN 47734-3525 Ph: (616) 486-5750 | Patrick L Fabrizio, MD 100 Michigan St Ne, Grand Rapids, MI 49503-2560 Ph: (616) 391-1830 |
News Archive
A new paper published on the preprint server medRxiv in April 2020 suggests, based on mathematical models, that premature removal of lockdown restrictions in India could be highly counterproductive, enhancing the secondary spread of COVID-19, pushing up the number of fatalities and prolonging the course of the pandemic in India.
Uninterrupted treatment with dabigatran, a non-vitamin K antagonist oral anticoagulant (NOACs), before, during and after ablation to treat atrial fibrillation significantly reduced the incidence of major bleeding events compared with uninterrupted use of the more established anticoagulant warfarin, according to research presented at the American College of Cardiology's 66th Annual Scientific Session.
News reports of a teenager unable to free a toddler from a burning vehicle's child safety seat helped convince a Rome, Ga. dentist his idea of an alternative quick release mechanism for such seats was needed.
Senetek PLC today announced the closing of a Security Purchase Agreement, a Note and a Warrant Purchase Agreement DMRJ Group, LLC on March 4, 2010. DMRJ Group, LLC is a Delaware limited liability company affiliated with Platinum Partners Value Arbitrage Fund L.P., an accredited institutional investor with its investment manager headquartered in New York, New York.
The U.S. Food and Drug Administration today approved two new drugs, Tafinlar (dabrafenib) and Mekinist (trametinib), for patients with advanced (metastatic) or unresectable (cannot be removed by surgery) melanoma, the most dangerous type of skin cancer.
› Verified 6 days ago
Dr. Jon R Henke, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Geoffrey M. Remes, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Jan L Mourelatos, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-361-5828 | |
Dr. Brendan Michael Banyon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 | |
Dr. Joseph J Junewick, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Keith Alan Morrow, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Dr. Andrew Kent Moriarity, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 |